NABTTNew Approaches to Brain Tumor Therapy
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
The first IL13-PE38 clinical study is being conducted through the NCI Clinical Trial Evaluation Program (CTEP)-funded New Approaches to Brain Tumor Therapy (NABTT) Consortium.
The names and Web site addresses of the two consortia are New Approaches to Brain Tumor Treatment (NABTT; and North American Brain Tumor Coalition (NABTC;
According to the NABTT Web site, these institutions offer (a) a large adult patient population with primary brain tumors; (b) expert multidisciplinary clinical teams caring for these patients; (c) extensive clinical and laboratory resources; (d) a striking number of ongoing high-quality, clinically relevant, peer-reviewed, and National Institutes of Health (NIH)-funded clinical and laboratory brain tumor research projects; (e) nationally recognized expertise in oncology, pharmacology, and new drug development Phase I and II clinical trials and neurosurgery and neuropathology departments; and (f) extensive expertise in biostatistics, data management, and the coordination of multi-institutional studies.